ADAMS W ANDREW - 02 May 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Reporting relationship: Director
Issuer ticker: NHC
Reported as of: 02 May 2025
Net transaction value: +$484,800
SEC form: 4
Accepted by SEC: 06 May 2025, 17:16:39 UTC
Prior SEC filing: 03 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ W. Andrew Adams

Key filing fact

ADAMS W ANDREW filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 06 May 2025.

Key facts

This page summarizes ADAMS W ANDREW's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
2 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 06 May 2025, 17:16.

Change

Previous filing in this sequence was filed on 03 Oct 2024.
Current net transaction value: +$484,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001012853 Primary reporting owner

ADAMS W ANDREW

Relationship: Director
Address: 100 VINE STREET, MURFREESBORO
Signature: /s/ W. Andrew Adams
Signature date: 06 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHC transaction

Shares of Common Stock - Revocable Living Trust

Options Exercise

Transaction value: $484,800
Shares: +7,500
Change %: +2.9%
Price: $64.64
Shares after: 269,572
Date: 02 May 2025
Ownership: Direct
Footnotes: F1

NHC holding

Shares of Common Stock - WAA Exempt Trust

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 399,929
Date: 02 May 2025
Ownership: Direct

NHC holding

Shares of Common Stock - Adams Family Foundation II

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,407
Date: 02 May 2025
Ownership: Trustee

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHC transaction Derivative

Option to Purchase Common Stock [2020 Grant]

Options Exercise

Transaction value: $0
Shares: -7,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 02 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $64.64
Footnotes: F1

NHC holding Derivative

Option to Purchase Common Stock [2021 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 02 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $71.64

NHC holding Derivative

Option to Purchase Common Stock [2022 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 02 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $69.19

NHC holding Derivative

Option to Purchase Common Stock [2023 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 02 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $55.75

NHC holding Derivative

Option to Purchase Common Stock [2024 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 02 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $96.03

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).